Artemether
CAS No. 71963-77-4
Artemether( Falcidol | Larither | Malartem | Paluther | SM-224 )
Catalog No. M15754 CAS No. 71963-77-4
Artemether is an antimalarial agent used to treat acute uncomplicated malaria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 51 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 66 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameArtemether
-
NoteResearch use only, not for human use.
-
Brief DescriptionArtemether is an antimalarial agent used to treat acute uncomplicated malaria.
-
DescriptionArtemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
-
In VitroWestern Blot Analysis Cell Line:RAW264.7 cells (treated with 100?ng/mL RANKL) Concentration:10 μM Incubation Time:6 h Result:Inhibited the activation of MAPK subfamilies, including ERK, JNK, and p38.Cell Cycle Analysis Cell Line:ConA-stimulated T lymphocytes Concentration:1, 10 and 50?μM Incubation Time:72 h Result:Arrested 47, 56 and 91% (at 1, 10 and 50?μM) of the cells at G0/G1 phases, respectively.
-
In VivoAnimal Model:LPS (5 mg/kg) treated mice Dosage:10 mg/kg Administration:i.p., 8 days Result:Prevented LPS induced osteolytic bone loss and the reduction in bone volume. Increased bone volume/total volume (BV/TV), decreased osteoclast surface/bone surface (Oc.S/BS) and number of TRAP-positive cells.
-
SynonymsFalcidol | Larither | Malartem | Paluther | SM-224
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number71963-77-4
-
Formula Weight298.38
-
Molecular FormulaC16H26O5
-
Purity>98% (HPLC)
-
SolubilityEthanol: 60 mg/mL (201.09 mM); DMSO: 60 mg/mL (201.09 mM)
-
SMILESC[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C
-
Chemical Name(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Humic acid
Humic acid is a compound formed by microbial decomposition of plant and animal remains and is widely found in mountains, rivers and lakes.Humic acid enhances the degradation of pyrene by Mycobacterium smegmatis NJS-1.
-
Betamethasone disodi...
Betamethasone disodium phosphate (Betamethasone 21-phosphate disodium salt) is a corticosteroid with anti-inflammatory properties that promotes the polarization of M1 to M2 macrophages by reducing the secretion of pro-inflammatory cytokines, and is utilized in research on keloids and rheumatoid arthritis.
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.
Cart
sales@molnova.com